Literature DB >> 21775537

Detection of extended-spectrum-beta-lactamase-positive Escherichia coli in bile isolates from two dogs with bacterial cholangiohepatitis.

Dorina Timofte1, Julien Dandrieux, Andrew Wattret, Jenny Fick, Nicola J Williams.   

Abstract

This is the first report of Escherichia coli isolates producing CTX-M-15, the predominant type of extended-spectrum β-lactamase (ESBL) associated with clinical disease in humans in the United Kingdom, in a United Kingdom pet dog. This report also describes the first isolation of CTX-M/Tem ESBL-positive E. coli from bile in dogs with hepatobiliary disease.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21775537      PMCID： PMC3165582          DOI： 10.1128/JCM.01045-11

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  23 in total

1.  Extended-spectrum beta-lactamase detected in E coli recovered from calves in Wales.

Authors:  C J Teale; L Barker; A P Foster; E Liebana; M Batchelor; D M Livermore; E J Threlfall
Journal:  Vet Rec       Date:  2005-02-05       Impact factor: 2.695

2.  Extended-spectrum beta-lactamase-producing bacteria isolated from companion animals.

Authors:  S I Steen; P J Webb
Journal:  Vet Rec       Date:  2007-11-17       Impact factor: 2.695

3.  Molecular characterization of plasmids encoding CTX-M-15 beta-lactamases from Escherichia coli strains in the United Kingdom.

Authors:  E Karisik; M J Ellington; R Pike; R E Warren; D M Livermore; N Woodford
Journal:  J Antimicrob Chemother       Date:  2006-07-26       Impact factor: 5.790

4.  CTX-M: changing the face of ESBLs in the UK.

Authors:  D M Livermore; P M Hawkey
Journal:  J Antimicrob Chemother       Date:  2005-07-08       Impact factor: 5.790

5.  bla(CTX-M) genes in clinical Salmonella isolates recovered from humans in England and Wales from 1992 to 2003.

Authors:  M Batchelor; K Hopkins; E J Threlfall; F A Clifton-Hadley; A D Stallwood; R H Davies; E Liebana
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

6.  Bacterial cholangitis/cholangiohepatitis with or without concurrent cholecystitis in four dogs.

Authors:  E J O'Neill; M J Day; E J Hall; D J Holden; K F Murphy; F J Barr; G R Pearson
Journal:  J Small Anim Pract       Date:  2006-06       Impact factor: 1.522

7.  Complete nucleotide sequence of a 92-kilobase plasmid harboring the CTX-M-15 extended-spectrum beta-lactamase involved in an outbreak in long-term-care facilities in Toronto, Canada.

Authors:  David A Boyd; Shaun Tyler; Sara Christianson; Allison McGeer; Matthew P Muller; Barbara M Willey; Elizabeth Bryce; Michael Gardam; Patrice Nordmann; Michael R Mulvey
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

8.  Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum beta-lactamases in the UK.

Authors:  N Woodford; M E Ward; M E Kaufmann; J Turton; E J Fagan; D James; A P Johnson; R Pike; M Warner; T Cheasty; A Pearson; S Harry; J B Leach; A Loughrey; J A Lowes; R E Warren; D M Livermore
Journal:  J Antimicrob Chemother       Date:  2004-09-03       Impact factor: 5.790

9.  Bacterial culture results from liver, gallbladder, or bile in 248 dogs and cats evaluated for hepatobiliary disease: 1998-2003.

Authors:  Karin A Wagner; Faye A Hartmann; Lauren A Trepanier
Journal:  J Vet Intern Med       Date:  2007 May-Jun       Impact factor: 3.333

10.  Confirmational identification of Escherichia coli, a comparison of genotypic and phenotypic assays for glutamate decarboxylase and beta-D-glucuronidase.

Authors:  A E McDaniels; E W Rice; A L Reyes; C H Johnson; R A Haugland; G N Stelma
Journal:  Appl Environ Microbiol       Date:  1996-09       Impact factor: 4.792
View more
  3 in total

1.  High prevalence of extended-spectrum β-lactamase, plasmid-mediated AmpC, and carbapenemase genes in pet food.

Authors:  Salome N Seiffert; Alessandra Carattoli; Regula Tinguely; Agnese Lupo; Vincent Perreten; Andrea Endimiani
Journal:  Antimicrob Agents Chemother       Date:  2014-08-04       Impact factor: 5.191

2.  Bacterial Cholangitis, Cholecystitis, or both in Dogs.

Authors:  A Tamborini; H Jahns; H McAllister; A Kent; B Harris; F Procoli; K Allenspach; E J Hall; M J Day; P J Watson; E J O'Neill
Journal:  J Vet Intern Med       Date:  2016-05-20       Impact factor: 3.333

3.  Cholangitis and Cholangiohepatitis in Dogs: A Descriptive Study of 54 Cases Based on Histopathologic Diagnosis (2004-2014).

Authors:  J L Harrison; B J Turek; D C Brown; C Bradley; J Callahan Clark
Journal:  J Vet Intern Med       Date:  2017-11-13       Impact factor: 3.333
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.